Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N K Sekaran"'
Autor:
Anisha Pauline P, C. S. Prakash, M. D. Anaesthesiology, C. Dhanasekaran, M. Dakshinamoorthy, N. K. Sekaran
Publikováno v:
Journal of Medical Science And clinical Research. :13317-13324
Rocuronium bromide introduced in 1994 was a non depolarizing muscle relaxant which became the first competitor to succinylcholine by producing excellent to good intubating conditions at 60 seconds. It had an intermediate duration of action with minim
Autor:
Christopher B. Granger, N K Sekaran, H V Anderson, Joan E. Booth, Nathan R. Every, Shelly Sapp, J J Ferguson, Christopher P. Cannon, David J. Moliterno, William J. French, Frank V. Aguirre
Publikováno v:
Journal of Thrombosis and Thrombolysis. 12:207-216
Background and Methods: Because time to presentation to the hospital affects time to treatment and is known to be important in acute myocardial infarction, we evaluated this variable in patients with unstable angina/non-ST segment elevation myocardia
Publikováno v:
International Journal of Advances in Scientific Research. 2:169
Introduction: Femur fractures are very painful. The peripheral nerve block provides good analgesia in these patients before performing regional anesthesia. This study aims to compare 2 local anesthestics in femoral nerve block for analgesia in preope
Autor:
N K, Sekaran, D J, Moliterno, J J, Ferguson, N, Every, H V, Anderson, F V, Aguirre, W J, French, S, Sapp, J E, Booth, C B, Granger, C P, Cannon
Publikováno v:
Journal of thrombosis and thrombolysis. 12(3)
Because time to presentation to the hospital affects time to treatment and is known to be important in acute myocardial infarction, we evaluated this variable in patients with unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI)
Autor:
David H. Au, N. K. Sekaran, D. Y. Wu, Jeffrey Crawford, Steven B. Zeliadt, David C. Dale, Gary H. Lyman, C. G. Slatore
Publikováno v:
Journal of Clinical Oncology. 28:6056-6056
6056 Background: The recently established VA Oncology Registry (VAOR) offers the ability to identify newly diagnosed patients with cancer treated at VA Medical Centers, for whom detailed clinical information can be linked to VA electronic medical dat